Life ScienceCompany
Catalyst Biosciences - Protease Medicines Ownership
Who owns Catalyst Biosciences - Protease Medicines?
Catalyst Biosciences - Protease Medicines is owned by Vertex Pharmaceuticals. It was acquired on May 23, 2022.
Catalyst Biosciences - Protease Medicines Business Overview
Where is Catalyst Biosciences - Protease Medicines headquartered?
Catalyst Biosciences - Protease Medicines is headquartered in San Francisco, California.
What sector is Catalyst Biosciences - Protease Medicines in?
Catalyst Biosciences - Protease Medicines is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 296 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 259 by strategics.